Page last updated: 2024-08-24

5-bromo-4-chloro-3-indolyl beta-galactoside and Experimental Hepatoma

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Experimental Hepatoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eguchi, K; Hamasaki, K; Ichikawa, T; Ishikawa, H; Matsumoto, K; Nakao, K; Nishimura, D1
Herberman, RB; Hirabayashi, H; Lin, WC; Vujanovic, NL; Whiteside, TL; Yasumura, S1

Other Studies

2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Experimental Hepatoma

ArticleYear
Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma.
    Gut, 2004, Volume: 53, Issue:6

    Topics: Animals; beta-Galactosidase; Bone Marrow Transplantation; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Female; Galactosides; Graft Survival; Hepatocytes; Immunohistochemistry; Indoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Transgenic; Stem Cells; Survival Rate

2004
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
    Cancer research, 1994, Jul-15, Volume: 54, Issue:14

    Topics: Animals; Female; Galactosides; Humans; Immunotherapy, Adoptive; Indoles; Interleukin-2; Killer Cells, Lymphokine-Activated; Lac Operon; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Stomach Neoplasms; Tumor Cells, Cultured

1994